Molok, Akiyyah D.
HRN: 22-13-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2023
CEFUROXIME 750MG (VIAL)
08/25/2023
08/31/2023
IV
300mg
Q8h
Acute Gastroenteritis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes